Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer

BACKGROUND: We have previously reported that expression of the Wnt antagonist genes SFRP1 and SFRP5 is frequently silenced by promoter hypermethylation in breast cancer. SFRP2 is a further Wnt inhibitor whose expression was recently found being downregulated in various malignancies. Here we investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeck, Jürgen, Noetzel, Erik, Bektas, Nuran, Jost, Edgar, Hartmann, Arndt, Knüchel, Ruth, Dahl, Edgar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613402/
https://www.ncbi.nlm.nih.gov/pubmed/18990230
http://dx.doi.org/10.1186/1476-4598-7-83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613402/
https://www.ncbi.nlm.nih.gov/pubmed/18990230
http://dx.doi.org/10.1186/1476-4598-7-83

Ejemplares similares